Gsk (GSK) Cash from Operations (2009 - 2026)
Gsk's Cash from Operations came in at $1.82 billion for the quarter ended Mar 31, 2026, up 11.1% from $1.64 billion a year earlier.
Gsk (GSK) Cash from Operations (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Gsk reported Cash from Operations of $1.75 billion, down 76.6% year-over-year; for the year ended Dec 31, 2025, it came in at $10.21 billion, up 21.8% from the prior year.
- Cash from Operations carries a five-year compound annual growth rate of -1.2% (years ended Dec 2020 to Dec 2025).
- Going back by year, Cash from Operations was $8.38 billion in the year ended Dec 31, 2024 (-0.5%), $8.42 billion in the year ended Dec 31, 2023 (-8.1%), $9.16 billion in the year ended Dec 31, 2022 (-16.3%) and $10.94 billion in the year ended Dec 31, 2021 (+0.9%).
- The figure for the quarter ended Mar 31, 2026 represents the highest quarterly Cash from Operations since the quarter ended Sep 30, 2024.
- Year-over-year, Cash from Operations increased in two of the last five quarters, with an average decline of 6.4%.
- The fastest year-over-year change in Cash from Operations over five years came in the quarter ended Mar 31, 2022 (growth of 548.5%), and the weakest in the quarter ended Mar 31, 2023 (a decline of 88.2%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 11.40 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 2.87 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | 5.04 Bn |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 835.00 Mn |
| 10 | Gsk | 100.27 Bn | 83.11 Bn | 8.73 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | -3.35 Bn |
| Mar 31, 2025 | 1.64 Bn |
| Dec 31, 2024 | 1.64 Bn |
| Sep 30, 2024 | 2.80 Bn |
| Jun 30, 2024 | 1.40 Bn |
| Mar 31, 2024 | 1.43 Bn |
| Dec 31, 2023 | 2.92 Bn |
| Sep 30, 2023 | 2.80 Bn |
| Jun 30, 2023 | 1.64 Bn |
| Mar 31, 2023 | 348.85 Mn |
| Dec 31, 2022 | 3.13 Bn |
| Mar 31, 2022 | 2.96 Bn |
| Dec 31, 2021 | 5.44 Bn |
| Mar 31, 2021 | 456.42 Mn |
| Dec 31, 2020 | 5.09 Bn |
| Sep 30, 2020 | 1.11 Bn |
| Jun 30, 2020 | 3.43 Bn |
| Mar 31, 2020 | 1.24 Bn |
| Dec 31, 2019 | 4.44 Bn |
Gsk Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();